High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil

Figure 1

Frequency of HIV-1 drug resistance mutations according to inhibitor class and TAMs detected in 82 individuals. (a) DRM to NRTI: nucleoside reverse transcriptase inhibitors (91.5%, ). (b) DRM to NNRTI: nonnucleoside reverse transcriptase inhibitor (84.1%, ). (c) DRM to PI: protease inhibitors (17%, n =14/82). (d) Thymidine analog mutations TAM [TAM-1 (), TAM-2 ()].

(a)

(b)

(c)

(d)